Skip to main content

Table 4 Relevant patients’ characteristics and treatment outcome (retrospective participants)

From: Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria

  Treatment outcome, n (%)  
Variable Cured Treatment Completed Defaulted Failed treatment Died Transferred out
Treatment outcome rate (%), n = 2262 53.5 25.6 10.6 2.4 7.8  
Age (year)
 18–34 619 (51.1) 210 (36.2) 128 (53.3) 21 (38.9) 51 (28.8) 66 (51.9)
 35–54 469 (38.7) 272 (46.9) 83 (35.6) 26 (48.1) 85 (48.0) 43 (33.9)
  ≥ 55 123 (10.2) 98 (16.9) 29 (12.1) 7 (13.0) 41 (23.2) 18 (14.2)
 Total 1211 (100.0) 580 (100.0) 240 (100.0) 54 (100.0) 177 (100.0) 127 (100.0)
Sex
 Male 724 (59.9) 304 (52.4) 160 (66.7) 35 (66.8) 111 (62.7) 72 (56.7)
 Female 487 (40.2) 276 (47.6) 80 (33.3) 19 (35.2) 66 (37.3) 55 (43.3)
 Total 1211 (100,0) 580 (100.0) 240 (100.0) 54 (100.0) 177 (100.0) 127 (100.0)
HIV status (n = 2117)
 Positive 129 (11.5) 171 (30.4) 67 (30.5) 9 (18.0) 51 (31.9) 28 (27.2)
 Negative 995 (88.5) 392 (69.6) 153 (69.5) 41 (82.0) 109 (68.1) 75 (72.8)
 Total 1124 (100.0) 563 (100.0) 220 (100.0) 50 (100.0) 160 (100.0) 103 (100.0)
DOT clinic attended
 UCH 251 (20.7) 389 (67.1) 115 (47.9) 18 (33.3) 86 (48.6) 75 (59.1)
 GCHJ 960 (79.3) 191 (32.9) 125 (52.1) 36 (65.7) 91 (51.4) 52 (40.9)
 Total 1211 (100.0) 580 (100.0) 240 (100.0) 54 (100.0) 177 (100.0) 127 (100.0)
Year of enrolment
 2013 207 (17.1) 118 (20.3) 33 (13.3) 7 (13.0) 32 (18.1) 34 (26.8)
 2014 286 (23.6) 104 (17.9) 56 (23.3) 9 (16.7) 38 (21.5) 30 (23.6)
 2015 197 (16.3) 93 (16.0) 39 (16.2) 8 (14.8) 28 (15.8) 28 (22.0)
 2016 285 (23.5) 98 (16.9) 52 (21.7) 10 (18.5) 41 (23.2) 30 (23.6)
 2017 236 (19.5) 167 (28.8) 60 (25.0) 20 (37.0) 38 (21.5) 5 (3.9)
 Total 1211 (100.0) 580 (100.0) 240 (100.0) 54 (100.0) 177 (100.0) 127 (100.0)
  1. Treatment outcome rate was calculated as the total number each of TB patients who were cured, completed treatment, defaulted, failed treatment and died, divided by the total number of patients placed on TB treatment (Y), multiply by 100, where Y = 2262. Transferred out patients were not part of the calculation for treatment outcome since they were not on TB treatment. HIV Human Immunodeficiency Virus, UCH University College Hospital, GJCH Government Jericho Chest Hospital, DOT Directly Observed Therapy, on TB treatment. Level of statistical significance, p < 0.05, n number